Skip to content

"Facing Death. . . Now, That's a Serious Thing to Confront" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.

Haley D M Schuman, Sofia Barkova, Raèf Mina, Julie M Deleemans, Tina Nguyen, Linda E Carlson

Integrative cancer therapies January 1, 2025 DOI: 10.1177/15347354251370982 via PubMed

Summary

AI-generated from the abstract

People with cancer often experience deep existential distress that standard psychosocial care does not adequately address. In this qualitative study, 15 participants with various cancer types and stages shared their views on psychedelic-assisted therapy (PAT) as a possible way to relieve psychosocial suffering, especially existential and emotional distress. Four main themes emerged: cautious optimism and differing attitudes toward specific psychedelics; the influence of relationships, stigma, and cultural framing; structural barriers like cost, legality, and unequal access; and the cancer context itself, where unmet needs for existential and spiritual support are common, particularly after active treatment or at advanced stages. Participants saw PAT as a potential adjunct to conventional care but raised concerns about safety, access, and stigma, highlighting the need for equitable, patient-informed implementation.

Study at a glance

Characteristics Qualitative study Peer reviewed
Sample size 15
Population People living with cancer (varying types and stages) recruited from a national survey
Intervention psychedelic-assisted therapy
Topics End-of-life distress Psilocybin Psychedelic-assisted therapy
Keywords Psychosocial symptoms Pat Psilocybin therapy
Citations 2
Key finding Participants expressed cautious optimism about psychedelic-assisted therapy as a potential adjunct to address existential and emotional distress in cancer care, but identified barriers including safety concerns, stigma, cost, legality, and unequal access.

Abstract

People living with cancer (PLWC) often face profound existential distress that is insufficiently addressed by conventional psychosocial supports. This qualitative study explored PLWC's attitudes, beliefs, and experiences regarding psychedelic-assisted therapy (PAT) as a novel approach to addressing psychosocial suffering, particularly existential distress. Fifteen participants with varying cancer types and stages were recruited from a national survey. Semi-structured interviews were analyzed using reflexive thematic analysis informed by the Theory of Planned Behavior. Four key themes were identified: (1) Cautious Optimism and Substance-Specific Attitudes Toward Psychedelics reflected varied knowledge, openness, and perceptions of specific agents; (2) Relational and Societal Influences: Stigma, Support, and Cultural Framing; (3) Structural and Systemic Barriers: Cost, Legality, Provider Attitudes, and Unequal Access; and (4) Cancer Context and Psychosocial Needs: Seeking Relief from Existential and Emotional Distress captured the emotional, spiritual, and existential dimensions of living with and beyond cancer. Participants expressed cautious optimism about PAT, driven by unmet needs in conventional care, particularly after active treatment and at advanced stages of cancer, where existential and spiritual concerns often go unaddressed. PAT was seen as a potential adjunct that could meaningfully engage with suffering beyond symptom management. However, concerns about safety, access, and stigma underscore the need for culturally responsive, patient-informed, and equity-focused implementation strategies. Integrating PAT into oncology will require dismantling structural barriers and shifting toward a model of care that embraces the full human experience of serious illness.

Explore topics

Comments

No comments yet.

Log in to comment